CSF Aβ42 predicts early-onset dementia in Parkinson disease
To test in vivo the proposal from clinicopathologic studies that β-amyloid (Aβ) pathology shortens the time to dementia in Parkinson disease (PD), and to explore the utility of CSF Aβ and related measures as early prognostic biomarkers of dementia in an incident PD cohort. We assessed a population-b...
Saved in:
Published in | Neurology Vol. 82; no. 20; p. 1784 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
20.05.2014
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!